Generic name:mirabegron (oral route) [ mir-a-BEG-ron ]
Drug class:Urinary antispasmodics
Medically reviewed by Drugs.com. Last updated on Feb 22, 2022.
Commonly used brand name(s)
In the U.S.
- Myrbetriq
- Myrbetriq Granules
Available Dosage Forms:
- Powder for Suspension, Extended Release
- Tablet, Extended Release
Therapeutic Class: Urinary Enuresis Agent
Pharmacologic Class: Beta-3 Adrenergic Agonist
Uses for Myrbetriq Granules
Mirabegron is used alone or together with other medicines (eg, solifenacin succinate) to treat the symptoms of an overactive bladder (OAB), such as incontinence (loss of bladder control), a strong need to urinate right away, or a frequent need to urinate. It is also used to treat neurogenic detrusor overactivity (NDO). Mirabegron works on the muscles of the bladder to increase the amount of urine your bladder can hold and prevent them from causing incontinence.
This medicine is available only with your doctor's prescription.
Before using Myrbetriq Granules
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of mirabegron oral liquid to treat NDO in children 3 years of age and older and the extended-release tablet to treat NDO in children 3 years of age and older and weighing 35 kilograms (kg) or more. Safety and efficacy have not been established to treat NDO in children younger than 3 years of age or to treat O...
